Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

27.16
Delayed Data
As of Dec 09
 +0.89 / +3.39%
Today’s Change
25.55
Today|||52-Week Range
35.04
-20.00%
Year-to-Date
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results
Dec 09 / TheStreet.com - Paid Partner Content
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
Dec 07 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
Dec 09 / Zacks.com - Paid Partner Content
8 Uncommon Stocks NWQ Managers Is Buying
Dec 06 / GuruFocus News - Paid Partner Content
Analysts' Actions -- Autodesk, Aflac, AstraZeneca, Duluth and More
Dec 09 / TheStreet.com - Paid Partner Content
Frontrunning: December 5
Dec 05 / Investing Channel - Paid Partner Content
Top Research Reports for Cisco, Merck & MasterCard
Dec 07 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
3 Horrible Stocks for Retirees
Nov 30 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close26.27
Today’s open26.71
Day’s range26.70 - 27.42
Volume8,677,307
Average volume (3 months)6,019,031
Market cap$66.5B
Dividend yield5.15%
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-1.08%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)-5.11%
P/E ratio28.0
Price/Sales3.48
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+1.08+3.09%
AGNAllergan+3.78+2.01%
LLYEli Lilly and Co+0.66+0.98%
ABTAbbott Laboratories+0.52+1.34%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts


Search for Jobs